The Goldman Sachs Group Boosts Teladoc Health (NYSE:TDOC) Price Target to $16.00

Teladoc Health (NYSE:TDOC) had its price target increased by equities research analysts at The Goldman Sachs Group from $14.00 to $16.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the health services provider’s stock. The Goldman Sachs Group’s price target suggests a potential upside of 22.00% from the company’s previous close.

Several other analysts have also issued reports on the company. Deutsche Bank Aktiengesellschaft upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Oppenheimer lowered their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Barclays increased their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Finally, TD Cowen lowered their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.18.

Teladoc Health Stock Down 8.5 %

NYSE TDOC traded down $1.22 during trading hours on Tuesday, hitting $13.12. 16,470,000 shares of the company traded hands, compared to its average volume of 6,729,508. The business’s 50-day moving average is $10.36 and its 200-day moving average is $9.32. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $20.88. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market capitalization of $2.26 billion, a price-to-earnings ratio of -2.27 and a beta of 1.05.

Insider Transactions at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new position in Teladoc Health during the 4th quarter valued at about $29,000. Lindbrook Capital LLC boosted its stake in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 1,612 shares during the last quarter. Blue Trust Inc. boosted its stake in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares during the last quarter. Finally, Sterling Capital Management LLC boosted its stake in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after buying an additional 4,101 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.